News

Reshaping pharmaceutical marketing: the new normal concept

It must be recognised that there are two complexities in defining a future scenario, one is the...

Continue reading

Reshaping pharmaceutical marketing: do sales reps shower in the morning or in the evening?

This question might seem bizarre, but instead it stems from a sharp reflection of a McKinsey global...

Continue reading

Reshaping pharmaceutical marketing: the VUCA world and the war

The theme of the VUCA world (which I dealt with in this article), i.e. volatile, uncertain, complex...

Continue reading

Reshaping pharmaceutical marketing: patients are the engine

Pharmaceutical Sales Representative is changing.The patient changes the Pharmaceutical Sales...

Continue reading

Reshaping pharmaceutical marketing: why not develop MSL?

Just for those who are now approaching pharmaceutical marketing, I would like to clarify that the...

Continue reading

Reshaping pharmaceutical marketing: the VUCA world, adapt or perish

For years, indeed decades, marketing structures have been able to draw up (and largely comply with)...

Continue reading

Reshaping pharmaceutical marketing: training is unproductive and needs to be cut

Training in pharmaceutical marketing in Italy is an unproductive expense and should be cut if you...

Continue reading

Reshaping pharmaceutical marketing: targeting is spam

Flyers work, we get them every day; email spam works, we experience it every day. But in pharma,...

Continue reading

Reshaping pharmaceutical marketing: the rising costs of traditional marketing

I do not believe that the traditional channels of pharmaceutical marketing no longer work. I don't...

Continue reading

Reshaping pharmaceutical marketing: from resilience to flexibility

Resilience means the ability to withstand impacts, shocks without suffering a disastrous breakdown,...

Continue reading